Received Aug 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 6 | 3031283 | IM / LA |
Reported Symptoms: 1002424:ANGIOEDEMA; 10042691:SWELLING OF FACE; 10054496:EDEMA MOUTH; Narrative: Pt is a 81 y/o who received his 6th COVID-19 injection into left deltoid. Following injection administration, left jaw swelling/warm to touch noted. Patient seen in the ED for orofacial angioedema with a localized reaction without anaphylaxis and provided with acetaminophen and methylprednisolone IV doses x 1. ACEI also discontinued. Decreased swelling noted following methylprednisolone dose. Other Relevant HX: Per ED notes: "#Acute orofacial angioedema/localized reaction without anaphylxis following COVID-19 booster (Moderna), improved: - Improved, but not fully resolved following Methylprednisolone 40mg IV x1 - Acetaminophen 650mg x 1 administered in fast track Pt was seen for orofacial swelling following his COVID-19 vaccination. As he is also on lisinopril, opted to discontinue and start amplodipine for hypertension. Given a potential drug-drug interaction between simvastatin and amlodipine, stopped simvastatin and started atorvastatin. He was given 7 day course of cetirizine 10mg BID to start the evening of 10/26 and a 5 day course or prednisone 20mg to start 10/27. He may not need to take the prednisone, but opted to provide as a true allergic reaction cannot be fully excluded at this time." Other: FACIAL SWELLING; ORAL SWELLING